Home/Filings/4/0001209191-24-002935
4//SEC Filing

Wasserman Chad J 4

Accession 0001209191-24-002935

CIK 0000860730other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 6:28 PM ET

Size

15.0 KB

Accession

0001209191-24-002935

Insider Transaction Report

Form 4
Period: 2024-02-02
Wasserman Chad J
SVP and CIO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-03+127417.31 total
  • Sale

    Common Stock

    2024-02-02$312.04/sh652$203,451290.31 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-03127128 total
    Exp: 2031-02-03Common Stock (127 underlying)
  • Tax Payment

    Common Stock

    2024-02-03$309.42/sh38$11,758379.31 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.0111 to $312.06, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
  • [F3]Restricted stock units convert into common stock on a one-for-one basis.
  • [F4]The restricted stock units vest in two equal annual installments beginning February 3, 2024.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0002010252

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:28 PM ET
Size
15.0 KB